Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclosporine, tolerance, and autoimmunity

G J Prud'homme1, L E Vanier

  • 1Department of Pathology, McGill University, Montreal, Quebec, Canada.

Clinical Immunology and Immunopathology
|March 1, 1993
PubMed
Summary

Cyclosporine A (CsA) can paradoxically block immunologic tolerance induction and promote autoimmune diseases by inhibiting key tolerance mechanisms like T-cell anergy and suppressor cell function. Understanding these complex effects is crucial for managing CsA

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellular immune abnormalities and autoreactive T lymphocytes in insulin-dependent diabetes mellitus in rats.

Immunology today·2014
Same author

B-cell hyperactivity in murine lupus I. Immunological abnormalities in lupus-prone strains and the activation of normal B cells.

Immunology today·2014
Same author

B-cell hyperactivity in murine lupus II. Defects in response to and production of accessory signals in lupus-prone mice.

Immunology today·2014
Same author

In vivo expression of GLP-1/IgG-Fc fusion protein enhances beta-cell mass and protects against streptozotocin-induced diabetes.

Gene therapy·2007
Same author

Plasmid-based gene therapy of diabetes mellitus.

Gene therapy·2007
Same author

Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice.

Gene therapy·2006

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • Cyclosporine A (CsA) is known for inducing immunologic tolerance, particularly in allograft transplantation.
  • Recent findings indicate CsA can also impair tolerance induction and exacerbate autoimmune diseases.

Purpose of the Study:

  • To investigate the multifaceted effects of CsA on immunologic tolerance mechanisms.
  • To elucidate how CsA interferes with processes maintaining self-tolerance.

Main Methods:

  • Review of existing studies on CsA's impact on T-cell selection, anergy, and suppressor cell function.
  • Analysis of CsA's effects on thymic negative selection and peripheral T-cell responses.
  • Examination of CsA's influence on Th1/Th2 balance and neonatal tolerance induction.

Main Results:

  • CsA can inhibit negative selection in the thymus and anergy induction in mature T-cells.
  • The drug's effects on T-cell deletion and suppressor cell function are variable and dose-dependent.
  • CsA can disrupt Th1/Th2 antagonism, enhance delayed-type hypersensitivity (DTH), and prevent neonatal tolerance.

Conclusions:

  • CsA's impact on tolerance is complex, involving inhibition of multiple mechanisms like clonal deletion, anergy, and suppressor cell activity.
  • The drug's ability to provoke autoimmunity likely stems from its interference with redundant tolerance pathways.
  • Further research is needed to fully understand CsA's role in autoimmunity and its effects on conventional antigens.

Related Experiment Videos